LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
---|---|---|---|---|---|
10057-1 | MK2206 | LSM-1057 | 24964624 | ||
10140-1 | Momelotinib | CYT387 | LSM-1141 | 25062766 | |
10018-1 | Neratinib | HKI-272 | LSM-42778 | 53398697 | |
10099-1 | Nilotinib | AMN-107 | LSM-1099 | 644241 | |
10151-1 | Nintedanib | BIBF-1120; Vargatef | LSM-1152 | 56965894 | |
10061-1 | NU7441 | KU 57788 | LSM-1061 | 11327430 | |
10122-1 | NVP-AEW541 | AEW541 | LSM-44953 | 11476171 | |
10024-1 | NVP-TAE684 | TAE-684 | LSM-1024 | 16038120 | |
10146-1 | Omipalisib | GSK2126458; GSK2126458A | LSM-1147 | 25167777 | |
10063-1 | OSI-027 | LSM-1063 | 56965966 | ||
10071-1 | Palbociclib | PD0332991 | LSM-1071 | 5330286 | |
10101-1 | PD0325901 | PD-325901 | LSM-1101 | 9826528 | |
10026-1 | PD173074 | LSM-1026 | 1401 | ||
10048-1 | PD184352 | CI-1040 | LSM-1048 | 6918454 | |
10159-1 | Pelitinib | EKB-569 | LSM-1160 | 216467 | |
10116-1 | PF431396 | LSM-1116 | 11598628 | ||
10112-1 | PF477736 | LSM-1112 | 16750408 | ||
10072-1 | PF562271 | KIN001-205 | LSM-1072 | 11713159 | |
10125-1 | PHA-665752 | LSM-42793 | 66596670 | ||
10073-1 | PHA-793887 | LSM-1073 | 46191454 | ||
10126-1 | PI103 | LSM-1126 | 9884685 | ||
10047-1 | Pictilisib | Pictrelisib; GDC-0941; RG-7321 | LSM-1047 | 17755052 | |
10190-1 | PIK-93 | LSM-1191 | 6852167 | ||
10049-1 | PLX-4720 | LSM-1049 | 24180719 | ||
10075-1 | QL-X-138 | LSM-5803 |